November 19, 2010: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Agenda
Meeting #49, November 19, 2010
Hilton Hotel, Gaithersburg, MD
Open Session (Grand Ballroom)
Call to Order and Opening Remarks
Conflict of Interest Statement
Recognition of Committee Service
Replication Competent Retrovirus Testing at the Indiana University Vector Production Facility
Kenneth Cornetta, M.D.
|10:45||RCL Lot Release Testing for Lentiviral Vector |
Laurent Humeau, Ph.D.
|12:30 p.m.||Findings and Challenges in Product Testing and Patient Monitoring for RCR/L in Gene Therapy Clinical Trials|
Gwendolyn K. Binder-Scholl, Ph.D.
University of Pennsylvania School of Medicine
|12:55||NCI Experience Using Engineered T cells for the Treatment of Cancer (Implication for RCR Testing)|
Richard A. Morgan, Ph.D.
National Cancer Institute
|1:20||Clinical Experience at Baylor College of Medicine with |
T Lymphocytes Genetically Modified Using Retroviral Vectors
Gianpietro G. Dotti, M.D.
Baylor College of Medicine
|1:45||Open Public Hearing|
|3:00||Committee Discussion of Questions|